Learnings about the complexity of extracellular tau aid development of a blood‐based screen for Alzheimer's disease-Reference-Cited by-同舟云学术

Learnings about the complexity of extracellular tau aid development of a blood‐based screen for Alzheimer's disease

Published:2018-11-09 Issue:3 Volume:15 Page:487-496
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Chen Zhicheng¹,Mengel David¹,Keshavan Ashvini²,Rissman Robert A.³⁴,Billinton Andrew⁵,Perkinton Michael⁵,Percival‐Alwyn Jennifer⁵,Schultz Aaron⁶,Properzi Michael⁶,Johnson Keith⁶,Selkoe Dennis J.¹,Sperling Reisa A.¹,Patel Purvish⁷,Zetterberg Henrik²⁸⁹¹⁰,Galasko Douglas³,Schott Jonathan M.²,Walsh Dominic M.¹²

Affiliation:

1. Laboratory for Neurodegenerative ResearchAnn Romney Center for Neurologic DiseasesBrigham and Women's Hospital and Harvard Medical SchoolBostonMAUSA

2. Department of Neurodegenerative DiseaseUCL Institute of NeurologyQueen SquareLondonEngland

3. Department of NeurosciencesUniversity of California San DiegoLa JollaCAUSA

4. VA San Diego Healthcare SystemLa JollaCAUSA

5. AstraZeneca Neuroscience Innovative MedicinesMedImmune LtdCambridgeEngland

6. Massachusetts General Hospital and Harvard Medical SchoolCharlestownMAUSA

7. Quanterix CorporationLexingtonMAUSA

8. UK Dementia Research Institute at UCLLondonEngland

9. Clinical Neurochemistry LaboratorySahlgrenska University HospitalMölndalSweden

10. Department of Psychiatry and NeurochemistryInstitute of Neuroscience and PhysiologySahlgrenska Academy at the University of GothenburgMölndalSweden

Funder

Medimmune

Leonard Wolfson Experimental Neurology Center

Weston Brain Institute

Wolfson Foundation

German Research Foundation

DFG

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.09.010

Reference33 articles.

1. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques

2. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

3. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

4. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

5. The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy;Brain Sciences;2024-08-26

2. Associations of Plasma Tau with Amyloid and Tau PET: Results from the Community-Based Framingham Heart Study;Journal of Alzheimer's Disease;2024-07-16

3. Neuroprotective role of Fisetin in Alzheimer's disease: An overview of potential mechanism and clinical findings;Neurology Letters;2024-06-20

4. Plasma NT1 tau is associated with hypometabolism in Alzheimer’s disease continuum;Neurology Letters;2024-06-18

5. Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting;Molecular Neurodegeneration;2024-05-15